Goat Feed · Guidance

    Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT

    Successful exploitation of these vulnerabilities could allow an attacker to obtain sensitive health-related information and prevent legitimate users from establishing a connection with the device.

    Back to the daily feed
    Guidance
    notable

    Blue Goat analysis

    Scored with Blue Goat's medical device cybersecurity risk methodology: STRIDE classification and CVSS v4.0 exploitability, with a severity-of-harm readout for your own ISO 14971 hazard analysis.

    The APG-01 BT is a Bluetooth-connected blood glucose meter. CISA's advisory covers two vulnerabilities in firmware 0x0110_v1.1.0. CISA reports the vendor did not respond to its requests to coordinate, so no fix has been published.

    CVEWhat an attacker can doSTRIDECVSS v4.0 ExploitabilitySecurity impact
    CVE-2026-50034An attacker within BLE range can passively intercept wireless traffic and obtain health-related information (CWE-319)Information disclosureMediumHigh
    CVE-2026-52866An attacker within BLE range can occupy the device's only BLE connection slot, so legitimate users can't connect (CWE-862)Denial of serviceMediumHigh

    Both published vectors need no privileges and no user action, but require Bluetooth range. That's why Exploitability reads Medium. Each has one High impact. On Blue Goat's security matrix, both are High as published.

    The published vectors describe the product as CISA scored it, not your device. If you build on this product or a similar component, score your own deployment with the CVSS v4.0 environmental metrics before you rate your risk.

    Severity from your hazard analysisSafety risk at Medium exploitability
    NegligibleLow
    Minor or SeriousMedium
    Critical or CatastrophicHigh

    Glucose readings drive insulin dosing decisions. Readings that can be intercepted, or a meter that can't sync, affects how a patient manages their diabetes.

    What to check now

    1. Encrypt every BLE characteristic that carries health data. Cleartext BLE can be captured passively, without the device ever knowing.
    2. Check how your device behaves when its connection slots are occupied, and whether a legitimate user can recover.
    3. For APG-01 BT users, there's no vendor fix. CISA recommends following its guidance on Bluetooth technology.
    4. If you're not affected, record that in a VEX statement with the justification.
    5. Re-score each affected threat in your cybersecurity risk assessment, and carry any patient-harm result into your ISO 14971 file.

    This analysis is informational. It is based on CISA's published advisory and does not assess any specific manufacturer's device.

    Other items reviewed by the Blue Goat team.

    Need help acting on this?

    Talk to Blue Goat Cyber

    Penetration testing, SBOM, threat modeling, and 524B submission support for MedTech.